These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 24861617)

  • 1. CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing.
    Montague TG; Cruz JM; Gagnon JA; Church GM; Valen E
    Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W401-7. PubMed ID: 24861617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering.
    Labun K; Montague TG; Gagnon JA; Thyme SB; Valen E
    Nucleic Acids Res; 2016 Jul; 44(W1):W272-6. PubMed ID: 27185894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing.
    Labun K; Montague TG; Krause M; Torres Cleuren YN; Tjeldnes H; Valen E
    Nucleic Acids Res; 2019 Jul; 47(W1):W171-W174. PubMed ID: 31106371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR Genome Editing Made Easy Through the CHOPCHOP Website.
    Labun K; Krause M; Torres Cleuren Y; Valen E
    Curr Protoc; 2021 Apr; 1(4):e46. PubMed ID: 33905612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
    Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
    Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences.
    Lin Y; Cradick TJ; Brown MT; Deshmukh H; Ranjan P; Sarode N; Wile BM; Vertino PM; Stewart FJ; Bao G
    Nucleic Acids Res; 2014 Jun; 42(11):7473-85. PubMed ID: 24838573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
    Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
    Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-TALEN: a web tool to design TALENs for genome engineering.
    Heigwer F; Kerr G; Walther N; Glaeser K; Pelz O; Breinig M; Boutros M
    Nucleic Acids Res; 2013 Nov; 41(20):e190. PubMed ID: 24003033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
    Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
    BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.
    Cram D; Kulkarni M; Buchwaldt M; Rajagopalan N; Bhowmik P; Rozwadowski K; Parkin IAP; Sharpe AG; Kagale S
    BMC Plant Biol; 2019 Nov; 19(1):474. PubMed ID: 31694550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
    Doench JG; Fusi N; Sullender M; Hegde M; Vaimberg EW; Donovan KF; Smith I; Tothova Z; Wilen C; Orchard R; Virgin HW; Listgarten J; Root DE
    Nat Biotechnol; 2016 Feb; 34(2):184-191. PubMed ID: 26780180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool.
    Stemmer M; Thumberger T; Del Sol Keyer M; Wittbrodt J; Mateo JL
    PLoS One; 2015; 10(4):e0124633. PubMed ID: 25909470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome engineering via TALENs and CRISPR/Cas9 systems: challenges and perspectives.
    Mahfouz MM; Piatek A; Stewart CN
    Plant Biotechnol J; 2014 Oct; 12(8):1006-14. PubMed ID: 25250853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced guide-RNA design and targeting analysis for precise CRISPR genome editing of single and consortia of industrially relevant and non-model organisms.
    Mendoza BJ; Trinh CT
    Bioinformatics; 2018 Jan; 34(1):16-23. PubMed ID: 28968798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
    Hendriks WT; Jiang X; Daheron L; Cowan CA
    Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool.
    Ronda C; Pedersen LE; Hansen HG; Kallehauge TB; Betenbaugh MJ; Nielsen AT; Kildegaard HF
    Biotechnol Bioeng; 2014 Aug; 111(8):1604-16. PubMed ID: 24827782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A web tool for the design of prime-editing guide RNAs.
    Chow RD; Chen JS; Shen J; Chen S
    Nat Biomed Eng; 2021 Feb; 5(2):190-194. PubMed ID: 32989284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases.
    Zhu LJ; Lawrence M; Gupta A; Pagès H; Kucukural A; Garber M; Wolfe SA
    BMC Genomics; 2017 May; 18(1):379. PubMed ID: 28506212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.